Allergy-Related Psychological Distress Common
Findings seen among adults and children with food allergies, as well as caregivers of children with food allergies
Clinical Response Seen for Patients With Severe Asthma Initiating Biologics
Responses more frequent in initiators than noninitiators, but 40 to 50 percent of initiators did not meet response criteria
Histologic Response Up With Benralizumab for Eosinophilic Esophagitis
Significantly more patients had histologic response with benralizumab than placebo, but no significant difference seen in dysphagia symptoms
Dupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis
Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen
Aerobic Exercise Tied to Improved Clinical Asthma Outcomes
Benefits include asthma-related quality of life and asthma control
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months
Decrease seen across sociodemographic and geographic characteristics, including sex, family income, education, region, urbanization level
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They’re Set to Expire
Approximately 7 Percent of U.S. Population Uninsured in 2023
10.9 percent of adults aged 18 to 64 years were uninsured at the time of interview in 2023, as were 3.9 percent of children aged 0 to 17 years
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
Findings seen despite negligible remaining lebrikizumab serum concentrations following treatment withdrawal
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
